Trial intelligence / Profile preview

Adductor Canal Blockade vs Femoral Nerve Blockade After Total Knee Arthroplasty

2012-004554-28Phase 3Completed

Sponsor
Rigshospitalet
Start
Dec 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Rigshospitalet. Primary endpoint: Change in quadriceps muscle strength (MVIC). Started Dec 2012; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2012-004554-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004554-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call